Whole body PD-1 and PD-L1 PET with Zr-89-nivolumab and F-18-BMS-986192 in pts with NSCLC.

Anna-Larissa N. Niemeijer, Egbert F. Smit, G. A. M. S. van Dongen, A. D. Windhorst, Marc C. Huisman, N. Harry Hendrikse, David K. Leung, Ralph Adam Smith, Wendy Hayes, Erik Thunnissen, Alex J. Poot, Danielle J. Vugts

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
JournalJournal of clinical oncology
Volume35
DOIs
Publication statusPublished - 20 May 2017

Cite this